SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-015225
Filing Date
2024-06-03
Accepted
2024-06-03 20:00:14
Documents
1
Period of Report
2024-05-31

Document Format Files

Seq Description Document Type Size
1 form4-06032024_080610.html 4  
1 form4-06032024_080610.xml 4 4134
  Complete submission text file 0001415889-24-015225.txt   5662
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Issuer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KALA PHARMACEUTICALS, INC. 490 ARSENAL WAY, SUITE 120 WATERTOWN MA 02472
Business Address
Kharabi Darius (Reporting) CIK: 0001893729 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38150 | Film No.: 241015694